Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Solution structure of recombinant human interleukin-6

G Y Xu1, H A Yu, J Hong

  • 1Small Molecule Drug Discovery, Genetics Institute, Cambridge, MA 02140, USA.

Journal of Molecular Biology
|May 2, 1997
PubMed
Summary

Researchers determined the solution structure of human interleukin-6 (hIL-6), a key cytokine involved in disease. This high-resolution NMR structure reveals a four-helix bundle crucial for understanding hIL-6 function and receptor interactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

[Mid-to long-term efficacy of drug-eluting stents for vertebral artery ostial stenosis].

Zhonghua yi xue za zhi·2026
Same author

Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

POSing the question: MARIPOSA-2, do the ends justify the means?

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Search for Heavy Neutral Leptons in Decays of W Bosons Using a Dilepton Displaced Vertex in sqrt[s]=13  TeV pp Collisions with the ATLAS Detector.

Physical review letters·2023

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Medicine

Background:

  • Interleukin-6 (IL-6) is a cytokine with critical biological roles.
  • Dysregulation of IL-6 is implicated in various diseases.
  • Understanding IL-6's structure is vital for therapeutic development.

Purpose of the Study:

  • To determine the high-resolution solution structure of recombinant human interleukin-6 (hIL-6).
  • To provide a structural basis for understanding IL-6's biological functions and receptor interactions.

Main Methods:

  • Utilized heteronuclear three- and four-dimensional Nuclear Magnetic Resonance (NMR) spectroscopy.
  • Employed distance geometry and simulated annealing protocols with 3044 restraints.
  • Generated an ensemble of 32 structures to represent the protein.

Related Experiment Videos

Main Results:

  • The hIL-6 structure features five alpha-helices, forming a classical four-helix bundle.
  • The core four-helix bundle is well-defined, with an average backbone RMSD of 0.50 A.
  • The N-terminal 19 amino acids are disordered, while the rest of the protein exhibits a stable structure.

Conclusions:

  • The determined NMR structure of hIL-6 provides detailed insights into its molecular architecture.
  • This structure rationalizes existing mutagenesis data regarding the heteromeric receptor complex.
  • The findings advance our understanding of IL-6 in health and disease.